A drug that targets the appetite control system in the brain could bring about significant weight loss in people with clinical obesity, according to new research. On average, people lost 5kg (11lbs) over a 12 week period after receiving weekly doses of semaglutide, a drug currently being developed as a treatment for diabetes. Most of the weight loss came from a reduction in body fat, researchers at the University of Leeds found, after reviewing its effectiveness.
Continue reading...
No comments:
Post a Comment